Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biocryst Pharmaceuticals

8.44
+0.12001.44%
Post-market: 8.40-0.0400-0.47%19:47 EDT
Volume:4.97M
Turnover:42.30M
Market Cap:1.76B
PE:-19.63
High:8.62
Open:8.43
Low:8.39
Close:8.32
Loading ...

BioCryst reports inducement grants under Nasdaq listing rule

TIPRANKS
·
06 Mar

BRIEF-Biocryst Pharmaceuticals Says CFO Anthony Doyle To Resign Effective April 9, 2025

Reuters
·
04 Mar

BioCryst Pharmaceuticals CFO Anthony Doyle to Step Down

MT Newswires Live
·
04 Mar

BioCryst CFO Anthony Doyle to resign, effective April 9

TIPRANKS
·
04 Mar

BioCryst Pharmaceuticals Inc - CFO Anthony Doyle to Resign Effective April 9, 2025

THOMSON REUTERS
·
04 Mar

BioCryst Pharmaceuticals Price Target Maintained With a $18.00/Share by Citizens Capital Markets

Dow Jones
·
03 Mar

Analysts Offer Insights on Healthcare Companies: Krystal Biotech (KRYS) and BioCryst (BCRX)

TIPRANKS
·
03 Mar

Is BioCryst Pharmaceuticals, Inc. (BCRX) the Best Small-Cap Stock to Buy Now?

Insider Monkey
·
01 Mar

BioCryst (BCRX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks
·
27 Feb

Here's Why BioCryst (BCRX) Could be Great Choice for a Bottom Fisher

Zacks
·
26 Feb

Analysts Are Updating Their BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Estimates After Its Yearly Results

Simply Wall St.
·
26 Feb

Evercore ISI Sticks to Their Buy Rating for BioCryst (BCRX)

TIPRANKS
·
26 Feb

BioCryst Pharmaceuticals Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow Jones
·
25 Feb

RBC Capital Adjusts Price Target on BioCryst Pharmaceuticals to $11 From $10, Keeps Outperform Rating

MT Newswires Live
·
25 Feb

BioCryst Pharmaceuticals Inc : Wedbush Initiates Coverage With Outperform Rating; Target Price $15

THOMSON REUTERS
·
25 Feb

BioCryst selloff yesterday brings buying opportunity, says JPMorgan

TIPRANKS
·
25 Feb

BioCryst Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.
·
25 Feb

Analysts Have Conflicting Sentiments on These Healthcare Companies: BioCryst (BCRX), Addus Homecare (ADUS) and Jazz Pharmaceuticals (JAZZ)

TIPRANKS
·
25 Feb

Q4 2024 BioCryst Pharmaceuticals Inc Earnings Call

Thomson Reuters StreetEvents
·
25 Feb

BioCryst Pharmaceuticals Inc (BCRX) Q4 2024 Earnings Call Highlights: Strong ORLADEYO Revenue ...

GuruFocus.com
·
25 Feb